Recent Major Transcriptomics and Epitranscriptomics Contributions toward Personalized and Precision Medicine.

With the advent of genome-wide screening methods-beginning with microarray technologies and moving onto next generation sequencing methods-the era of precision and personalized medicine was born. We show that leading advances are being made in both diagnostics, and in investigative and landscaping disease pathophysiological studies.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Genomics led the way, and its contributions are well recognized.
• 2 However, "other-omics" fields have rapidly emerged and are becoming as important toward defining disease causes and exploring therapeutic benefits.
• 3 In this review, we focus on the impacts of transcriptomics, and its extension-epitranscriptomics-on personalized and precision medicine efforts.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: